APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Transcranial Stimulation System

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-Invasive Transcranial Stimulation System Industry Growth and Trends Forecast to 2032

24 December 2025109 pages

Choose your research edition.

Industry ResearchNon-Invasive Transcranial Stimulation System Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Transcranial Stimulation System Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Non-Invasive Transcranial Stimulation System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Transcranial Stimulation System Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Transcranial Stimulation System Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Non-Invasive Transcranial Stimulation System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-Invasive Transcranial Stimulation System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-Invasive Transcranial Stimulation System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive Transcranial Stimulation System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Invasive Transcranial Stimulation System include Brainbox, Flow Neuroscience, lonclinics, Neurocare, NeuroCare Group, Neurolite, Newronika, Soterix Medical and Neuracle, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-Invasive Transcranial Stimulation System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-Invasive Transcranial Stimulation System market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-Invasive Transcranial Stimulation System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-Invasive Transcranial Stimulation System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-Invasive Transcranial Stimulation System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-Invasive Transcranial Stimulation System Market by Company

Brainbox

Flow Neuroscience

lonclinics

Neurocare

NeuroCare Group

Neurolite

Newronika

Soterix Medical

Neuracle

Volcan Medical

Non-Invasive Transcranial Stimulation System Segment by Type

Electrical Stimulation Type

Magnetic Stimulation Type

Non-Invasive Transcranial Stimulation System Segment by Application

Research

Medical

Others

Non-Invasive Transcranial Stimulation System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Transcranial Stimulation System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Transcranial Stimulation System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Transcranial Stimulation System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Invasive Transcranial Stimulation System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-Invasive Transcranial Stimulation System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Electrical Stimulation Type Table 2. Major Company of Magnetic Stimulation Type Table 3. Global Non-Invasive Transcranial Stimulation System Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (Units) Table 5. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type (2021-2026) Table 6. Global Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (US$ Million) Table 7. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type (2021-2026) Table 8. Global Non-Invasive Transcranial Stimulation System Price by Type (2021-2026) & (US$/Unit) Table 9. Global Non-Invasive Transcranial Stimulation System Sales by Type (2027-2032) & (Units) Table 10. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type (2027-2032) Table 11. Global Non-Invasive Transcranial Stimulation System Sales by Type (2027-2032) & (US$ Million) Table 12. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type (2027-2032) Table 13. Global Non-Invasive Transcranial Stimulation System Price by Type (2027-2032) & (US$/Unit) Table 14. North America Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (Units) Table 15. North America Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (Units) Table 17. Europe Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (Units) Table 21. Latin America Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Type (2021-2026) & (US$ Million) Table 24. Non-Invasive Transcranial Stimulation System Industry Trends Table 25. Non-Invasive Transcranial Stimulation System Industry Drivers Table 26. Non-Invasive Transcranial Stimulation System Industry Opportunities and Challenges Table 27. Non-Invasive Transcranial Stimulation System Industry Restraints Table 28. Global Non-Invasive Transcranial Stimulation System Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Non-Invasive Transcranial Stimulation System Revenue Market Share by Company (2021-2026) Table 30. Global Non-Invasive Transcranial Stimulation System Sales by Company (2021-2026) & (Units) Table 31. Global Non-Invasive Transcranial Stimulation System Sales Share by Company (2021-2026) Table 32. Global Non-Invasive Transcranial Stimulation System Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Non-Invasive Transcranial Stimulation System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Non-Invasive Transcranial Stimulation System Major Company Production Sites and Headquarters Table 35. Global Non-Invasive Transcranial Stimulation System Company, Product Type & Application Table 36. Global Non-Invasive Transcranial Stimulation System Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Non-Invasive Transcranial Stimulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Non-Invasive Transcranial Stimulation System Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Non-Invasive Transcranial Stimulation System Sales by Region (2021-2026) & (Units) Table 41. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Region (2021-2026) Table 42. Global Non-Invasive Transcranial Stimulation System Sales by Region (2021-2026) & (US$ Million) Table 43. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Region (2021-2026) Table 44. Global Non-Invasive Transcranial Stimulation System Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Non-Invasive Transcranial Stimulation System Sales by Region (2027-2032) & (Units) Table 46. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Region (2027-2032) Table 47. Global Non-Invasive Transcranial Stimulation System Sales by Region (2027-2032) & (US$ Million) Table 48. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Region (2027-2032) Table 49. Global Non-Invasive Transcranial Stimulation System Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Non-Invasive Transcranial Stimulation System Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (Units) Table 52. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application (2021-2026) Table 53. Global Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (US$ Million) Table 54. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application (2021-2026) Table 55. Global Non-Invasive Transcranial Stimulation System Price by Application (2021-2026) & (US$/Unit) Table 56. Global Non-Invasive Transcranial Stimulation System Sales by Application (2027-2032) & (Units) Table 57. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application (2027-2032) Table 58. Global Non-Invasive Transcranial Stimulation System Sales by Application (2027-2032) & (US$ Million) Table 59. Global Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application (2027-2032) Table 60. Global Non-Invasive Transcranial Stimulation System Price by Application (2027-2032) & (US$/Unit) Table 61. North America Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (Units) Table 62. North America Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (Units) Table 64. Europe Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (Units) Table 68. Latin America Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Application (2021-2026) & (US$ Million) Table 71. Brainbox Company Information Table 72. Brainbox Business Overview Table 73. Brainbox Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Brainbox Non-Invasive Transcranial Stimulation System Product Portfolio Table 75. Brainbox Recent Development Table 76. Flow Neuroscience Company Information Table 77. Flow Neuroscience Business Overview Table 78. Flow Neuroscience Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Flow Neuroscience Non-Invasive Transcranial Stimulation System Product Portfolio Table 80. Flow Neuroscience Recent Development Table 81. lonclinics Company Information Table 82. lonclinics Business Overview Table 83. lonclinics Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. lonclinics Non-Invasive Transcranial Stimulation System Product Portfolio Table 85. lonclinics Recent Development Table 86. Neurocare Company Information Table 87. Neurocare Business Overview Table 88. Neurocare Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Neurocare Non-Invasive Transcranial Stimulation System Product Portfolio Table 90. Neurocare Recent Development Table 91. NeuroCare Group Company Information Table 92. NeuroCare Group Business Overview Table 93. NeuroCare Group Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. NeuroCare Group Non-Invasive Transcranial Stimulation System Product Portfolio Table 95. NeuroCare Group Recent Development Table 96. Neurolite Company Information Table 97. Neurolite Business Overview Table 98. Neurolite Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Neurolite Non-Invasive Transcranial Stimulation System Product Portfolio Table 100. Neurolite Recent Development Table 101. Newronika Company Information Table 102. Newronika Business Overview Table 103. Newronika Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Newronika Non-Invasive Transcranial Stimulation System Product Portfolio Table 105. Newronika Recent Development Table 106. Soterix Medical Company Information Table 107. Soterix Medical Business Overview Table 108. Soterix Medical Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Soterix Medical Non-Invasive Transcranial Stimulation System Product Portfolio Table 110. Soterix Medical Recent Development Table 111. Neuracle Company Information Table 112. Neuracle Business Overview Table 113. Neuracle Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Neuracle Non-Invasive Transcranial Stimulation System Product Portfolio Table 115. Neuracle Recent Development Table 116. Volcan Medical Company Information Table 117. Volcan Medical Business Overview Table 118. Volcan Medical Non-Invasive Transcranial Stimulation System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Volcan Medical Non-Invasive Transcranial Stimulation System Product Portfolio Table 120. Volcan Medical Recent Development Table 121. North America Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 122. North America Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026) & (Units) Table 123. North America Non-Invasive Transcranial Stimulation System Sales Market Share by Country (2021-2026) Table 124. North America Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032) & (Units) Table 125. North America Non-Invasive Transcranial Stimulation System Sales Market Share Forecast by Country (2027-2032) Table 126. North America Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Non-Invasive Transcranial Stimulation System Market Share by Country (2021-2026) Table 129. North America Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Non-Invasive Transcranial Stimulation System Market Share Forecast by Country (2027-2032) Table 131. Europe Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 132. Europe Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026) & (Units) Table 133. Europe Non-Invasive Transcranial Stimulation System Sales Market Share by Country (2021-2026) Table 134. Europe Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032) & (Units) Table 135. Europe Non-Invasive Transcranial Stimulation System Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Non-Invasive Transcranial Stimulation System Market Share by Country (2021-2026) Table 139. Europe Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Non-Invasive Transcranial Stimulation System Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026) & (Units) Table 143. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032) & (Units) Table 145. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Share by Country (2021-2026) Table 149. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Share Forecast by Country (2027-2032) Table 151. Latin America Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 152. Latin America Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026) & (Units) Table 153. Latin America Non-Invasive Transcranial Stimulation System Sales Market Share by Country (2021-2026) Table 154. Latin America Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032) & (Units) Table 155. Latin America Non-Invasive Transcranial Stimulation System Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Non-Invasive Transcranial Stimulation System Market Share by Country (2021-2026) Table 159. Latin America Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Non-Invasive Transcranial Stimulation System Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026) & (Units) Table 163. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032) & (Units) Table 165. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Share by Country (2021-2026) Table 169. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Non-Invasive Transcranial Stimulation System Distributors List Table 174. Non-Invasive Transcranial Stimulation System Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Non-Invasive Transcranial Stimulation System Image Figure 2. Global Non-Invasive Transcranial Stimulation System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Invasive Transcranial Stimulation System Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Invasive Transcranial Stimulation System Sales (2021-2032) & (Units) Figure 5. Electrical Stimulation Type Image Figure 6. Global Electrical Stimulation Type Sales YoY Growth (2021-2032) & (Units) Figure 7. Magnetic Stimulation Type Image Figure 8. Global Magnetic Stimulation Type Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Non-Invasive Transcranial Stimulation System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Non-Invasive Transcranial Stimulation System Market Share by Type 2025 VS 2032 Figure 11. North America Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type in 2025 Figure 12. North America Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type in 2025 Figure 13. Europe Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type in 2025 Figure 14. Europe Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type in 2025 Figure 17. Latin America Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Non-Invasive Transcranial Stimulation System Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Research Image Figure 24. Global Research Sales YoY Growth (2021-2032) & (Units) Figure 25. Medical Image Figure 26. Global Medical Sales YoY Growth (2021-2032) & (Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Non-Invasive Transcranial Stimulation System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Non-Invasive Transcranial Stimulation System Market Share by Application 2025 VS 2032 Figure 31. North America Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application in 2025 Figure 32. North America Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application in 2025 Figure 33. Europe Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application in 2025 Figure 34. Europe Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application in 2025 Figure 37. Latin America Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Market Share in Value by Application in 2025 Figure 41. North America Non-Invasive Transcranial Stimulation System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Non-Invasive Transcranial Stimulation System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Non-Invasive Transcranial Stimulation System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Non-Invasive Transcranial Stimulation System Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Non-Invasive Transcranial Stimulation System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Non-Invasive Transcranial Stimulation System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non-Invasive Transcranial Stimulation System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Non-Invasive Transcranial Stimulation System Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Non-Invasive Transcranial Stimulation System Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Non-Invasive Transcranial Stimulation System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Non-Invasive Transcranial Stimulation System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non-Invasive Transcranial Stimulation System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Non-Invasive Transcranial Stimulation System Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Non-Invasive Transcranial Stimulation System Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Non-Invasive Transcranial Stimulation System Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Non-Invasive Transcranial Stimulation System Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Electrical Stimulation Type
  • Magnetic Stimulation Type
Applications
  • Research
  • Medical
  • Others
Companies covered
  • Brainbox
  • Flow Neuroscience
  • lonclinics
  • Neurocare
  • NeuroCare Group
  • Neurolite
  • Newronika
  • Soterix Medical
  • Neuracle
  • Volcan Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Invasive Transcranial Stimulation System Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-Invasive Transcranial Stimulation System Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-Invasive Transcranial Stimulation System Market by Type
  6. 1.3.1 Electrical Stimulation Type
  7. 1.3.2 Magnetic Stimulation Type
  8. 1.4 Global Non-Invasive Transcranial Stimulation System Market Size by Type
  9. 1.4.1 Global Non-Invasive Transcranial Stimulation System Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Non-Invasive Transcranial Stimulation System Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Non-Invasive Transcranial Stimulation System Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Non-Invasive Transcranial Stimulation System Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Non-Invasive Transcranial Stimulation System Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Non-Invasive Transcranial Stimulation System Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-Invasive Transcranial Stimulation System Industry Trends
  2. 2.2 Non-Invasive Transcranial Stimulation System Industry Drivers
  3. 2.3 Non-Invasive Transcranial Stimulation System Industry Opportunities and Challenges
  4. 2.4 Non-Invasive Transcranial Stimulation System Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-Invasive Transcranial Stimulation System Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-Invasive Transcranial Stimulation System Sales (2021-2026)
  3. 3.3 Global Top Players by Non-Invasive Transcranial Stimulation System Price (2021-2026)
  4. 3.4 Global Non-Invasive Transcranial Stimulation System Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Invasive Transcranial Stimulation System Major Company Production Sites & Headquarters
  6. 3.6 Global Non-Invasive Transcranial Stimulation System Company, Product Type & Application
  7. 3.7 Global Non-Invasive Transcranial Stimulation System Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Invasive Transcranial Stimulation System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Invasive Transcranial Stimulation System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Invasive Transcranial Stimulation System Tier 1, Tier 2, and Tier 3
4 Non-Invasive Transcranial Stimulation System Regional Status and Outlook
  1. 4.1 Global Non-Invasive Transcranial Stimulation System Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-Invasive Transcranial Stimulation System Historic Market Size by Region
  3. 4.2.1 Global Non-Invasive Transcranial Stimulation System Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-Invasive Transcranial Stimulation System Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-Invasive Transcranial Stimulation System Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-Invasive Transcranial Stimulation System Forecasted Market Size by Region
  7. 4.3.1 Global Non-Invasive Transcranial Stimulation System Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-Invasive Transcranial Stimulation System Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-Invasive Transcranial Stimulation System Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-Invasive Transcranial Stimulation System by Application
  1. 5.1 Non-Invasive Transcranial Stimulation System Market by Application
  2. 5.1.1 Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Non-Invasive Transcranial Stimulation System Market Size by Application
  6. 5.2.1 Global Non-Invasive Transcranial Stimulation System Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Non-Invasive Transcranial Stimulation System Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Non-Invasive Transcranial Stimulation System Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Non-Invasive Transcranial Stimulation System Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Non-Invasive Transcranial Stimulation System Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Non-Invasive Transcranial Stimulation System Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Brainbox
  2. 6.1.1 Brainbox Company Information
  3. 6.1.2 Brainbox Business Overview
  4. 6.1.3 Brainbox Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Brainbox Non-Invasive Transcranial Stimulation System Product Portfolio
  6. 6.1.5 Brainbox Recent Developments
  7. 6.2 Flow Neuroscience
  8. 6.2.1 Flow Neuroscience Company Information
  9. 6.2.2 Flow Neuroscience Business Overview
  10. 6.2.3 Flow Neuroscience Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Flow Neuroscience Non-Invasive Transcranial Stimulation System Product Portfolio
  12. 6.2.5 Flow Neuroscience Recent Developments
  13. 6.3 lonclinics
  14. 6.3.1 lonclinics Company Information
  15. 6.3.2 lonclinics Business Overview
  16. 6.3.3 lonclinics Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 lonclinics Non-Invasive Transcranial Stimulation System Product Portfolio
  18. 6.3.5 lonclinics Recent Developments
  19. 6.4 Neurocare
  20. 6.4.1 Neurocare Company Information
  21. 6.4.2 Neurocare Business Overview
  22. 6.4.3 Neurocare Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Neurocare Non-Invasive Transcranial Stimulation System Product Portfolio
  24. 6.4.5 Neurocare Recent Developments
  25. 6.5 NeuroCare Group
  26. 6.5.1 NeuroCare Group Company Information
  27. 6.5.2 NeuroCare Group Business Overview
  28. 6.5.3 NeuroCare Group Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NeuroCare Group Non-Invasive Transcranial Stimulation System Product Portfolio
  30. 6.5.5 NeuroCare Group Recent Developments
  31. 6.6 Neurolite
  32. 6.6.1 Neurolite Company Information
  33. 6.6.2 Neurolite Business Overview
  34. 6.6.3 Neurolite Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neurolite Non-Invasive Transcranial Stimulation System Product Portfolio
  36. 6.6.5 Neurolite Recent Developments
  37. 6.7 Newronika
  38. 6.7.1 Newronika Company Information
  39. 6.7.2 Newronika Business Overview
  40. 6.7.3 Newronika Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Newronika Non-Invasive Transcranial Stimulation System Product Portfolio
  42. 6.7.5 Newronika Recent Developments
  43. 6.8 Soterix Medical
  44. 6.8.1 Soterix Medical Company Information
  45. 6.8.2 Soterix Medical Business Overview
  46. 6.8.3 Soterix Medical Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Soterix Medical Non-Invasive Transcranial Stimulation System Product Portfolio
  48. 6.8.5 Soterix Medical Recent Developments
  49. 6.9 Neuracle
  50. 6.9.1 Neuracle Company Information
  51. 6.9.2 Neuracle Business Overview
  52. 6.9.3 Neuracle Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Neuracle Non-Invasive Transcranial Stimulation System Product Portfolio
  54. 6.9.5 Neuracle Recent Developments
  55. 6.10 Volcan Medical
  56. 6.10.1 Volcan Medical Company Information
  57. 6.10.2 Volcan Medical Business Overview
  58. 6.10.3 Volcan Medical Non-Invasive Transcranial Stimulation System Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Volcan Medical Non-Invasive Transcranial Stimulation System Product Portfolio
  60. 6.10.5 Volcan Medical Recent Developments
7 North America by Country
  1. 7.1 North America Non-Invasive Transcranial Stimulation System Sales by Country
  2. 7.1.1 North America Non-Invasive Transcranial Stimulation System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026)
  4. 7.1.3 North America Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-Invasive Transcranial Stimulation System Market Size by Country
  6. 7.2.1 North America Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-Invasive Transcranial Stimulation System Sales by Country
  2. 8.1.1 Europe Non-Invasive Transcranial Stimulation System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-Invasive Transcranial Stimulation System Market Size by Country
  6. 8.2.1 Europe Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Country
  2. 9.1.1 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size by Country
  6. 9.2.1 Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-Invasive Transcranial Stimulation System Sales by Country
  2. 10.1.1 South America Non-Invasive Transcranial Stimulation System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026)
  4. 10.1.3 South America Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-Invasive Transcranial Stimulation System Market Size by Country
  6. 10.2.1 South America Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Country
  2. 11.1.1 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-Invasive Transcranial Stimulation System Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size by Country
  6. 11.2.1 Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-Invasive Transcranial Stimulation System Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-Invasive Transcranial Stimulation System Value Chain Analysis
  2. 12.1.1 Non-Invasive Transcranial Stimulation System Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-Invasive Transcranial Stimulation System Production Mode & Process
  7. 12.2 Non-Invasive Transcranial Stimulation System Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-Invasive Transcranial Stimulation System Distributors
  10. 12.2.3 Non-Invasive Transcranial Stimulation System Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst